A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma	Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Phase 1 / Phase 2	2026-09-23		NCT07116616

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
ModernaTX, Inc.	41

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Atrium Health Levine Cancer Institute	Charlotte	United States	14
Emory University Hospital	Atlanta	United States	131
Mass General Brigham	Boston	United States	15
Memorial Sloan-Kettering Cancer Center	New York	United States	63
Penn Medicine	Philadelphia	United States	20
Sarah Cannon Research Institute	Nashville	United States	119
The Medical College of Wisconsin	Milwaukee	United States	17
Tisch Cancer Institute at Mount Sinai	New York	United States	1
UCSF	San Francisco	United States	27
University of Alabama at Birmingham Hospital	Birmingham	United States	3